Skip to main content

Table 1 Patient characteristics

From: Multifocal high-grade glioma radiotherapy safety and efficacy

Pat Age Sex Diag WHO IDH MGMT Resection KPS pre RT KPS post RT
1 50 Male GB IV IDH WT unmeth biopsy 70 70
2 84 Male GB IV IDH WT meth biopsy 80 80
3 68 Male GB IV IDH WT meth biopsy 80 70
4 70 Male GB IV IDH WT meth biopsy 90 90
5 74 Female GB IV IDH WT meth biopsy 60 50
6 62 Male GB IV IDH WT unmeth biopsy 90 80
7 63 Male GB IV IDH WT meth biopsy 90 80
8 50 Female GB IV IDH WT unmeth biopsy 90 80
9 68 Male GB IV IDH WT unmeth biopsy 60 50
10 64 Female GB IV IDH WT unmeth biopsy 80 70
11 53 Male GB IV IDH WT unmeth str 90 80
12 50 Male GB IV IDH WT unmeth biopsy 90 80
13 57 Female AA III IDH WT meth biopsy 90 70
14 42 Female GB IV IDH WT meth biopsy 80 70
15 62 Male GB IV IDH WT meth gtr 100 100
16 50 Female GB IV IDH WT meth biopsy 50 50
17 57 Male GB IV IDH WT meth biopsy 100 100
18 54 Female GB IV IDH WT meth biopsy 70 70
19 60 Male GB IV IDH WT unmeth biopsy 70 80
20 69 Male GB IV IDH WT unmeth biopsy 100 90
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us